This report focuses on the global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Cancer Diagnostics development in United States, Europe and China. In 2017, the global Next Generation Cancer Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study Cepheid Koninklijke Philips N.V F. Hoffmann-La Roche Ltd Qiagen Novartis AG Abbott Thermo Fisher Scientific Opko Health Myriad Genetics Agilent Technologies GE Healthcare PerkinElmer Genomic Health Illumina Hologic Almac Group Janssen Global Services Sysmex Corporation Market segment by Type, the product can be split into Next Generation Sequencing qPCR & Multiplexing DNA Microarrays Other Market segment by Application, split into Hospitals Clinics Other Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. To present the Next Generation Cancer Diagnostics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Next Generation Cancer Diagnostics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (2013-2025) 1.4.2 Next Generation Sequencing 1.4.3 qPCR & Multiplexing 1.4.4 DNA Microarrays 1.4.5 Other 1.5 Market by Appl
